 Prostatic Neoplasms
"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
| Descriptor ID |
D011471
|
| MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
| Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 5 | 7 | | 1997 | 2 | 0 | 2 | | 1998 | 4 | 1 | 5 | | 1999 | 8 | 0 | 8 | | 2000 | 8 | 2 | 10 | | 2001 | 4 | 0 | 4 | | 2002 | 19 | 2 | 21 | | 2003 | 24 | 1 | 25 | | 2004 | 29 | 2 | 31 | | 2005 | 28 | 0 | 28 | | 2006 | 34 | 7 | 41 | | 2007 | 35 | 6 | 41 | | 2008 | 41 | 6 | 47 | | 2009 | 30 | 2 | 32 | | 2010 | 25 | 6 | 31 | | 2011 | 29 | 4 | 33 | | 2012 | 38 | 6 | 44 | | 2013 | 27 | 7 | 34 | | 2014 | 31 | 3 | 34 | | 2015 | 41 | 4 | 45 | | 2016 | 33 | 6 | 39 | | 2017 | 17 | 6 | 23 | | 2018 | 29 | 5 | 34 | | 2019 | 28 | 1 | 29 | | 2020 | 19 | 2 | 21 | | 2021 | 23 | 1 | 24 | | 2022 | 14 | 0 | 14 | | 2023 | 10 | 1 | 11 | | 2024 | 24 | 1 | 25 | | 2025 | 13 | 1 | 14 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
Tomar MS, Raina K, Mishra N, Kant R, Fox JT, Agarwal C, Agarwal R. Distinct Tumor Infiltrating Immune Cell Profiles in Mice by Non-Steroidal Anti-Inflammatory Drugs (Aspirin and Naproxen) During TMPRSS2-ERG (Fusion)-Driven and Non-Fusion Driven Prostate Cancer. Mol Carcinog. 2026 May; 65(5):589-602.
-
Lucia MS, Callis S, Tangen C, Almutairi F, Chatzitolios A, Kravtsov O, Lenon S, Manuchua V, Simko JP, Szecsei CM, Yeh YA, Zhang L, Iczkowski KA. Whole-Slide Telepathology Grading of Prostate Cancer in Biopsies Using International Society of Urological Pathology Criteria: Interobserver and Intraobserver Concordance and Implications for Active Surveillance. J Urol. 2026 05; 215(5):544-552.
-
Zhao L, Imami MR, Wang Y, Mao Y, Hsu WC, Chen R, Mena E, Li Y, Tang J, Wu J, Voter AF, Amindarolzarbi A, Kargilis D, Afyouni S, Gafita A, Chen J, Chin BB, Leal JP, Du Y, Lin G, Jiao Z, Choyke PL, Rowe SP, Pomper MG, Liao W, Bai HX. Artificial intelligence-based lesion characterization and outcome prediction of prostate cancer on [18F]DCFPyL PSMA imaging. Radiother Oncol. 2026 01; 214:111265.
-
Spratt DE, Srinivas S, Adra N, Ahmed B, An Y, Bitting R, Chapin B, Cheng HH, Cho SY, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Ippolito JE, Karnes RJ, Kishan A, Kuettel MR, Lang JM, Lee D, Lotan T, McDonald A, Morgan T, Pessoa R, Rais-Bahrami S, Roach M, Robin T, Rosenfeld S, Scarpato KR, Shabsigh A, Szmulewitz R, Teply BA, Tward J, Valicenti R, VanderWeele D, Wong JK, Kovach E, Freedman-Cass D. Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 Nov; 23(11):469-493.
-
Song Y, Nguyen L, Dornisch AM, Baxter MT, Barrett T, Dale AM, Dess RT, Harisinghani M, Kamran SC, Liss MA, Margolis DJA, Weinberg EP, Woolen SA, Seibert TM. Urethra contours on MRI: Multidisciplinary consensus educational atlas and reference standard for artificial intelligence benchmarking. Radiother Oncol. 2026 01; 214:111231.
-
Graham LS, Yu EY. Early and Precise: Treating HRR Alterations in Hormone-Sensitive Prostate Cancer. Clin Cancer Res. 2025 Oct 01; 31(19):4001-4003.
-
Nguyen C, Hulsey G, James K, James T, Carlson JM. Deep Learning Classification of Prostate Cancer Using MRI Histopathologic Data. Radiol Imaging Cancer. 2025 09; 7(5):e240381.
-
Lin JK, Niu J, Giordano SH, Li P, Snyder RA, Liao K, Li M, Aparicio A, Chapin W, Zhang J, Xiang J, Perera N, Pain D, Guerra CE, Doshi JA. Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers. J Clin Oncol. 2025 Oct 20; 43(30):3254-3265.
-
Orman MV, Graham LS, Cramer SD, Costello JC. Systems biology successes and areas for opportunity in prostate cancer. Endocr Relat Cancer. 2025 Aug 01; 32(8).
-
Patel SA, Kollmeier M, Crook J, Krauss D, Morton G, Chang AJ, Helou J, Hsu IC, Menard C, Patel S, Robin T, Rossi PJ, Zelefsky MJ, Kamrava MR. High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statement. Brachytherapy. 2025 Sep-Oct; 24(5):644-662.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|